GoHealth (NASDAQ:GOCO) Stock Price Down 7.1% – Time to Sell?

Shares of GoHealth, Inc. (NASDAQ:GOCO) dropped 7.1% during trading on Friday . The stock traded as low as $2.98 and last traded at $3.00. Approximately 49,691 shares traded hands during mid-day trading, an increase of 40% from the average daily volume of 35,400 shares. The stock had previously closed at $3.23.

Wall Street Analyst Weigh In

GOCO has been the subject of a number of research analyst reports. Royal Bank Of Canada decreased their price objective on shares of GoHealth from $12.00 to $5.00 and set a “sector perform” rating for the company in a report on Wednesday, November 26th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of GoHealth in a research note on Monday, December 1st. Finally, William Blair reissued a “market perform” rating on shares of GoHealth in a research note on Wednesday, November 19th. One investment analyst has rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $5.00.

GoHealth Price Performance

The company has a current ratio of 1.64, a quick ratio of 1.64 and a debt-to-equity ratio of 2.64. The firm’s 50-day moving average price is $3.57 and its two-hundred day moving average price is $4.84. The stock has a market cap of $86.13 million, a PE ratio of -0.19 and a beta of 1.68.

GoHealth (NASDAQ:GOCO) last issued its quarterly earnings data on Thursday, November 13th. The company reported ($0.19) earnings per share (EPS) for the quarter, beating the consensus estimate of ($2.06) by $1.87. The company had revenue of $34.19 million for the quarter, compared to analyst estimates of $102.36 million. GoHealth had a negative net margin of 26.95% and a positive return on equity of 8.00%. On average, equities analysts expect that GoHealth, Inc. will post -5.5 earnings per share for the current fiscal year.

Institutional Investors Weigh In On GoHealth

A number of institutional investors have recently added to or reduced their stakes in GOCO. American Century Companies Inc. purchased a new position in GoHealth in the second quarter valued at about $63,000. Franklin Resources Inc. bought a new stake in shares of GoHealth in the 3rd quarter valued at about $66,000. Bank of America Corp DE grew its position in shares of GoHealth by 22.8% in the 4th quarter. Bank of America Corp DE now owns 7,831 shares of the company’s stock worth $105,000 after buying an additional 1,452 shares during the last quarter. Cubist Systematic Strategies LLC raised its stake in shares of GoHealth by 297.3% during the 1st quarter. Cubist Systematic Strategies LLC now owns 10,915 shares of the company’s stock worth $134,000 after acquiring an additional 8,168 shares in the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. lifted its position in GoHealth by 50.5% during the second quarter. Connor Clark & Lunn Investment Management Ltd. now owns 26,013 shares of the company’s stock valued at $144,000 after acquiring an additional 8,734 shares during the last quarter. Institutional investors own 24.21% of the company’s stock.

GoHealth Company Profile

GoHealth, Inc operates as a health insurance marketplace and Medicare-focused digital health company in the United States. The company operates a technology platform that leverages machine-learning algorithms of insurance behavioral data to optimize the process for helping individuals find the health insurance plan for their specific needs.